EP36 Hot Issue - Vaccines reduce long-term Covid-19 symptoms. episode artwork

EPISODE · Sep 13, 2021 · 32 MIN

EP36 Hot Issue - Vaccines reduce long-term Covid-19 symptoms.

from Hot Issue #whats4lunch by ACTnow · host ACTnow Community Mobile App

A new study of breakthrough Covid-19 infections finds that vaccines not only reduce the risk of severe disease and hospitalization, but can lower the odds of having long-term Covid-19 symptoms too. It shows that in the minority of people who get Covid despite two jabs, the odds of developing symptoms lasting longer than four weeks are cut by 50%. Vaccination, compared with no vaccination, was associated with reduced odds of Covid-19 hospitalization or having more than five symptoms in the first week of illness following a first or second dose.  The researchers found, and there were reduced odds of long-term symptoms lasting 28 days or more following a second vaccine dose. In terms of the burden of long Covid, it is good news that our research has found that having a double vaccination significantly reduces the risk of both catching the virus and, if you do, developing long-standing symptoms.

Episode metadata supplied by the publisher feed · Published Sep 13, 2021

Embed this episode

NOW PLAYING

EP36 Hot Issue - Vaccines reduce long-term Covid-19 symptoms.

0:00 32:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Hot Issue #whats4lunch by ACTnow?

This episode is 32 minutes long.

When was this Hot Issue #whats4lunch by ACTnow episode published?

This episode was published on September 13, 2021.

Can I download this Hot Issue #whats4lunch by ACTnow episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!